STAT

Opinion: It will take a village to solve the epidemic of maternal deaths in the U.S.

The phrase "maternal death" tends to conjure up images of uncontrollable bleeding after delivery or the Cesarean section that goes terribly wrong. But two-thirds of maternal deaths happen either before…

The phrase “maternal deaths” tends to conjure up images of awful complications of delivery: uncontrollable bleeding after birth or the Cesarean section that goes terribly wrong. But these heartbreaking catastrophes account for the minority of maternal deaths.

Two-thirds of them happen either before birth or more than a week after delivery. In most cases, the woman is home when whatever will kill her — uncontrolled high blood pressure, heart failure, blood clots, suicide, drug overdose

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related Books & Audiobooks